Clinical Trials · NCT01573806
Pharmacology of Exenatide in Pediatric Sepsis
- Phase
- Phase 1/Phase 2
- Recruitment status
- Withdrawn
- Sponsor
- Seattle Children's Hospital
- Enrollment
- 0
- Start date
- Oct 2012
- Locations
- 1 site, United States
- Primary endpoint
- Exenatide associated adverse event occurence